Company Overview - Altria Group, Inc. is valued at $109.1 billion and is a leading tobacco company based in Richmond, Virginia, owning brands like Marlboro, Black & Mild, and Copenhagen, with operations in smokeable products, oral tobacco, and wine [1] Upcoming Earnings - Altria is set to release its third-quarter results on October 30, with analysts expecting an adjusted EPS of $1.44, reflecting a 4.4% increase from $1.38 in the same quarter last year [2] - For fiscal 2025, the expected adjusted EPS is $5.43, which is a 6.1% increase from $5.12 in fiscal 2024 [3] Stock Performance - Over the past 52 weeks, Altria's shares have increased by 31.2%, outperforming the S&P 500 Index's return of 13.4% and the Consumer Staples Select Sector SPDR Fund's decline of 3.5% [4] Analyst Ratings - Bank of America Securities analyst Lisa Lewandowski has reaffirmed a "Buy" rating on Altria, leading to a 1.3% increase in share price following the announcement [5] - The consensus rating on Altria is neutral, with 15 analysts providing ratings: 4 "Strong Buy," 9 "Hold," 1 "Moderate Sell," and 1 "Strong Sell," with the stock trading slightly above the mean price target of $62.27 [6]

Core Viewpoint - Wall Street anticipates a year-over-year increase in earnings for Philip Morris, driven by higher revenues, with a focus on how actual results compare to estimates impacting stock price [1][2]. Earnings Expectations - Philip Morris is expected to report quarterly earnings of $2.10 per share, reflecting a +10% year-over-year change, and revenues of $10.66 billion, which is a 7.6% increase from the previous year [3]. Estimate Revisions - The consensus EPS estimate has been revised down by 0.02% over the last 30 days, indicating a collective reassessment by analysts [4]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that the Most Accurate Estimate for Philip Morris is lower than the consensus estimate, resulting in an Earnings ESP of -0.66%, suggesting bearish sentiment among analysts [12]. Historical Performance - Philip Morris has consistently beaten consensus EPS estimates in the past four quarters, with a notable surprise of +3.24% in the last reported quarter [13][14]. Investment Considerations - Despite the historical performance, the current combination of a negative Earnings ESP and a Zacks Rank of 3 makes it challenging to predict an earnings beat for Philip Morris [12][17].

Core Viewpoint - Altria's stock is considered undervalued, with its valuation reflecting negative free cash flow per share growth for the next decade [1] Group 1: Investment Strategy - The investment approach focuses on GARP (growth at a reasonable price) stocks while also seeking opportunities in other areas [1] - There is no specified time horizon for investments; the strategy is to hold stocks as long as the investment thesis remains valid [1] Group 2: Analytical Background - The analyst has developed market-beating algorithms using Python to identify attractive investment opportunities [1] - Previous experience includes roles at TipRanks as an analysis/news writer and editor, enhancing market awareness and understanding of reader interests [1] - The analyst emphasizes the importance of accuracy and detail in financial information, aiming to correct misinformation in the market [1]

Core Insights - Altria's stock is considered undervalued, with its valuation reflecting negative free cash flow per share growth for the next decade [1] - The investment strategy focuses on GARP (growth at a reasonable price) stocks while also exploring other opportunities [1] - The investment horizon is flexible, with a focus on holding stocks as long as the investment thesis remains valid [1] Company Analysis - Altria's current valuation suggests a pessimistic outlook, indicating potential for recovery if the company's fundamentals improve [1] - The analyst has developed algorithms to identify attractive investment opportunities, indicating a data-driven approach to investment [1] Market Context - The article emphasizes the importance of accurate information in the investment landscape, highlighting the prevalence of misinformation [1] - The analyst's background in writing and editing for financial news platforms contributes to a deeper understanding of market trends and investor interests [1]

Core Insights - The article discusses the author's journey in dividend growth investing and the establishment of a blog that documents this journey, aiming for financial independence [1]. Group 1 - The author has been investing since September 2017 and has a long-standing interest in dividend investing since around 2009 [1]. - The blog "Kody's Dividends" was launched in July 2018 to document the author's financial independence journey through dividend growth investing [1]. - The author expresses gratitude for the blog's role in connecting with the Seeking Alpha community as an analyst [1].

Core Insights - Altria Group, Inc.'s oral tobacco business is experiencing strong profitability, with adjusted operating companies income (OCI) margins increasing to 68.7% in Q2 2025, a rise of 3.1 percentage points year-over-year [1][8] - The growth driver is the on! nicotine pouches, which saw a volume increase of 26.5%, compensating for declines in traditional moist smokeless tobacco (MST) brands [2][8] - Sustaining profitability will depend on product mix, competitive pressures, and pricing dynamics in the nicotine pouch category [3][4] Oral Tobacco Business Performance - Altria's oral tobacco segment demonstrates strong operating efficiency despite a 1% dip in total shipment volumes [1][4] - The adjusted OCI increased by 10.9% due to strong pricing and cost efficiencies [2] - The share of on! in the nicotine pouch segment decreased by 2.3 percentage points to 16.7%, while its share in the total U.S. oral tobacco category rose to 8.7% [3] Competitive Landscape - Philip Morris International Inc. reported an adjusted operating income margin of 41.9% in Q2 2025, highlighting effective global pricing and cost management strategies [5] - Turning Point Brands, Inc. achieved a Stoker's products segment adjusted operating income margin of 44.3%, reflecting strong manufacturing efficiency and pricing power [6] Stock Performance and Valuation - Altria's shares have increased by 2.5% over the past month, contrasting with a 1.8% decline in the industry [7] - The forward price-to-earnings ratio for Altria is 12.02X, lower than the industry average of 14.68X [10] - Zacks Consensus Estimate indicates year-over-year earnings growth of 6.1% for 2025 and 2.5% for 2026 [11]

Group 1 - Philip Morris International Inc. (NYSE:PM) is recognized as a strong stock, with Jim Cramer highlighting it as one of his favorites despite personal reservations about its product line [1] - The company manufactures and sells cigarettes and smoke-free products, including IQOS and ZYN nicotine brands, and is actively working to transition away from traditional tobacco products [1] - Cramer acknowledges the company's strong performance and potential for continued success, although he refrains from recommending the stock due to its core business [1] Group 2 - The article suggests that while PM has investment potential, certain AI stocks may offer greater upside and lower downside risk, indicating a shift in investment focus [1]

Industry Overview - The Zacks Tobacco industry is facing significant challenges, including declining cigarette sales due to shifting consumer preferences, inflationary pressures, and tightening regulations [1][4] - Rising health awareness and stricter restrictions on smoking are reducing demand for traditional tobacco products, negatively impacting overall industry performance [1][4] Key Trends - **Challenges in Cigarette Sales Volumes**: The industry is experiencing a decline in cigarette sales driven by inflation and changing consumer spending patterns, alongside regulatory restrictions on sales and advertising [4] - **Escalated Costs**: Industry participants are affected by cost inflation related to essential materials, energy, and labor, which poses risks to profit margins [5] - **Rising Popularity of Smoke-Free Options**: There is a growing demand for smoke-free alternatives like heated tobacco and vapor products, driven by health awareness and regulatory changes [6] Industry Performance - The Zacks Tobacco industry currently ranks 165, placing it in the bottom 32% of over 243 Zacks industries, indicating dull near-term prospects [7][8] - The industry's consensus estimate for current financial year earnings has decreased by 1.2% since August 2025, reflecting a negative earnings outlook [9] Market Comparison - Over the past year, the Zacks Tobacco industry has outperformed the S&P 500, gaining 36.4% compared to the S&P 500's growth of 18.4% [11] Valuation Metrics - The industry is currently trading at a forward 12-month price-to-earnings (P/E) ratio of 14.44X, lower than the S&P 500's 23.53X and the sector's 16.37X [14] Company Highlights - **Philip Morris International**: This company is transitioning towards a smoke-free future, focusing on reduced-risk products (RRPs) and has seen a 30% increase in shares over the past year [17][19] - **Altria Group**: Altria is prioritizing RRPs and has experienced a 31.7% surge in shares over the past year, supported by its strong legacy brands [22][23] - **Turning Point Brands**: This company has gained momentum with a 105.8% increase in shares over the past year, focusing on innovative product launches and expanding distribution channels [26][28]

Core Viewpoint - Imperial Brands PLC continues to outperform its peers in the stock market, maintaining a strong performance over the past year [1]. Company Analysis - The last assessment of Imperial Brands PLC indicated that its stock performance was superior to that of its competitors, a trend that has persisted [1]. - The company is associated with a macroeconomist who has over 20 years of experience in investment management and related fields, suggesting a strong analytical backing for its market position [1]. Industry Context - The article references a broader investment theme focused on the green economy, indicating potential future opportunities in this segment, although it does not directly relate to Imperial Brands [1].

Core Insights - Altria offers a high dividend yield of 6.4% and has a strong history of regular dividend increases, making it attractive for income-focused investors [1] - However, the company's core cigarette business is facing significant challenges, including a long-term decline in smoking rates and a 10.2% year-over-year volume drop in Q2 2025 [4][5] - Altria's attempts to offset declining volumes through price increases are becoming less effective, with a 2.5% year-over-year revenue decline from smokeable products in Q2 2025 when excluding tobacco taxes [5] Company Overview - Altria primarily produces tobacco products, with cigarettes being its largest segment, alongside cigars, chewing tobacco, nicotine pouches, and vaping products [2] - The company is categorized as a "sin stock" due to the addictive nature of its products, which fosters customer loyalty similar to other consumer staples [3] Business Challenges - The long-term trend away from smoking poses a significant headwind for Altria, and its efforts to find new growth avenues have not yielded positive results, such as investments in Juul and Cronos leading to large write-offs [5][6] - Altria's decision to spin off Philip Morris International has created a new competitor in the U.S. market, as Philip Morris now sells non-cigarette nicotine products domestically [7] - Recent investments, such as the acquisition of NJOY, have also faced setbacks, including legal issues that hindered product sales [8] Investment Considerations - Despite the attractive dividend yield, the risks associated with Altria's business performance and strategic missteps may deter conservative dividend investors [9] - The company's future outlook appears uncertain, and the perceived safety of its dividend yield may be misleading [10]